High demand causes mumps vaccine shortage in Japan; OncoQCR's breast cancer vax succeeds in nonhuman primates;

> Higher-than-expected demand for the mumps vaccine has caused a shortage in Japan, though the shortfall is expected to be alleviated between next week and the end of November. Story

> OncoQCR's breast cancer vaccine candidate, OQR200, induced high levels of antibodies and T-cell responses to HER2/neu cancer cells in a nonhuman primate study. Release

Suggested Articles

Fujifilm says it is prepared to ramp up production of Avigan for any country that wants to try it as a potential treatment for COVID-19.

Pfizer posted positive top-line results for a trial of its 20-valent pneumococcal vaccine, potentially setting up a filing by the end of 2020.

Univercells's new CDMO, Exothera, is hoping to play a role in helping drugmakers scale up manufacturing for a possible COVID-19 vaccine.